Back

ASH 2020 - 62nd American Society of Hematology Annual Meeting and Exposition (Virtual Meeting)

Dec 05 - Dec 08, 2020 | San DiegoCAUS

LARVOL is not affiliated with 62nd American Society of Hematology Annual Meeting and Exposition (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners

Showing 1025 abstracts linked to Trials

[VIRTUAL] Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study

  • Oral
8 Twitter Reactions

[VIRTUAL] A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate. the Flight Trial

  • Late-Breaking
4 Twitter Reactions

[VIRTUAL] First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

  • Late-Breaking
4 Twitter Reactions